Healthcare Elites tracks global leaders like Tedros Adhanom, Emma Walmsley, and Kevin Lobo worldwide. 
Global health care leaders are in the spotlight due to the aging population, chronic diseases, digitalization of care, and health care equality. Such PPs as Emma Walmsley (GSK), Pascal Soriot (AstraZeneca), Tedros Adhanom Ghebreyesus (WHO), and Kevin Lobo (Stryker) are engaged in critical issues concerning the pharmaceutical industry and medical devices. The strategies of this market determine the development of innovative treatments, drug access, and the overall health care state in different countries. Moreover, the trends in the health care industry are connected with the increased role of technology.
In particular, networked solutions, artificial intelligence, and prevention-related approaches are being implemented in different areas of health care by hospitals, drug manufacturers, medical device companies, and government organizations. In this way, the most progressive leaders of the industry play a major role in its development. The growing importance of the health care sector attracts social media influencers, investors, and other actors of the international arena. The increasing attention to the topic is also due to the pharmaceutical industry’s transition to a more competitive environment where companies try to make medicines and devices available for as many people as possible.
In addition, the themes of access to care and affordable vaccines are critical for society and politics. The leaders of the industry, their professional behavior, and business strategies are of great interest to the public. Thus, the essence of global health care coverage, the impact of technology, and issues of accessibility and affordability are the factors attracting public attention and contributing to the popularity of health care elites.
